Reliability and validity of the functional assessment of cancer therapy- breast quality-of-life instrument

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 974-986

  Brady, M J ^a   Cella, D F ^a   Mo, F ^a   Bonomi, A E ^a   Tulsky, D S ^a   Lloyd, S R ^a   Deasy, S ^a   Cobleigh, M ^a   Shiomoto, G ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER THERAPY; CLINICAL PRACTICE; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; SELF REPORT; WELLBEING;

EID: 0031056944     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.974     Document Type: Article

References (42)

1. Parkin DM, Läärä E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-197, 1988
2. The American Cancer Society: Cancer Facts and Figures-1996. New York, NY, American Cancer Society, 1996
3. Garfinkel L, Boring CC, Heath CW Jr: Changing trends: An overview of breast cancer incidence and mortality. Cancer 74:222-227, 1994
4. Smigel, K: Breast cancer death rates decline for white women. J Natl Cancer Inst 87:173, 1995
5. Meyerowitz BE: Psychological correlates of breast cancer and its treatment. Psych Bull 87:108-131, 1980
6. Glanz K, Lerman C: Psychosocial impact of breast cancer: A critical review. Ann Behav Med 14:204-212, 1992
7. Levy SM, Haynes LT, Herberman RB, et al: Mastectomy versus breast conservation surgery: Mental health effects at long-term follow-up. Health Psych 11:349-354, 1992
8. Fallowfield L: Quality of life in breast cancer - Results from 3 Cancer Research Campaign studies. Acta Clin Belg 48:19-23, 1993
9. Sneeuw KCA, Aaronson NK, Yarold JR, et al: Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 2. Relationship with psychosocial functioning. Radiother Oncol 25:160-166, 1992
10. Kemeny MM, Wellisch DK, Schain WS: Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer. Cancer 62:1231-1237, 1988
11. Ganz PA, Schag AC, Lee JJ, et al: Breast conservation versus mastectomy: Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69:1729-1738, 1992
12. Coates A, Gebski V, Stat M, et al: Improving the quality of life during chemotherapy for advanced breast cancer. N Engl J Med 317:1490-1495, 1987
13. Knobt MT: Symptoms and rehabilitation needs of patients with early-stage breast cancer during primary therapy. Cancer 66:1392-1401, 1990
14. Johnson JR, Temple R: Food and drug administration requirements for approval of new anticancer drugs. Cancer Treat Rep 69:1155-1157, 1985
15. Nayfield SG, Ganz PA, Moinpour CM, et al: Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1:203-210, 1992
16. Priestman TJ, Baum M: Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 24:899-901, 1976
17. Levine MN, Guyatt GH, Gent M, et al: Quality of life in stage II breast cancer: An instrument for clinical trials. J Clin Oncol 6:1798-1810, 1988
18. Ganz PA, Schag CA, Lee JJ, et al: The CARES: A generic measure of health-related quality of life for patients with cancer. Qual Life Res 1:19-29, 1992
19. Schag CA, Ganz PA, Heinrich RL: Cancer Rehabilitation Evaluation System-Short Form (CARES-SF): A cancer specific rehabilitation and quality of life instrument. Cancer 68:1406-1413, 1991
20. Schipper H, Clinch J, McMurray A, et al: Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and Validation. J Clin Oncol 2:472-483, 1984
21. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy (FACT) Scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
22. Cella DF: F.A.C.T. Manual: Manual for the Functional Assessment of Cancer Therapy (FACT) scales and the Functional Assessment of HIV Infection (FAHI) scale. Chicago, IL, Rush-Presbyterian-St. Luke's Medical Center, 1994
23. Cella DF, Bonomi AE, Lloyd SR, et al: Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12:199-220, 1995
24. Bonomi AE, Cella DF, Hahn E, et al: Multilingual translation of the Functional Assessment of Cancer Therapy Measurement System. Qual Life Res 5:309-320, 1996
25. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
26. Osoba D, Zee B, Pater J, et al: Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 3:353-364, 1994
27. Sprangers MAG, Groenvold M, Arraras JI, et al: The European Organization for Research and Treatment of Cancer Breast Cancer-Specific Quality-of-Life Questionnaire Module: First results from a three-country field study. J Clin Oncol 14:2756-2768, 1996
28. Zubrod CG, Scneiderman M, Frie E, et al: Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 11:7-33, 1960
29. Bergman B, Aaronson NK, Ahmedzai S, et al: The EORTC QLQ-LC13: A modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 30:635-642, 1994
30. Ganz P, Haskell CM, Figlin RA, et al: Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index-Cancer. Cancer 61:849-856, 1988
31. Slevin ML, Plant H, Lynch D, et al: Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109-112, 1988
32. Moinpour CM, Savage M, Hayden KA, et al: Quality of life assessment in cancer clinical trials, in Dimsdale JE, Baum A (eds): Quality of Life in Behavioral Medicine Research. Hillsdale, NJ, Lawrence Erlbaum, 1995, pp 79-95
33. Loprinzi CL, Laurie JA, Wieand S: Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol 12:601-607, 1994
34. Cella DF, Jacobsen PB, Orav EJ, et al: A brief POMS measure of distress for cancer patients. J Chron Dis 40:939-942, 1987
35. Strahan R, Gerbasi KC: Short homogeneous versions of the Marlowe-Crowne Social Desirability Scale. J Clin Psychol 28:191-193, 1972
36. Helmstadter GC: Principles of Psychological Measurement. New York, NY, Appleton-Century-Crofts, 1964
37. Bergman B, Sullivan M, Sorenson S: Quality of life during chemotherapy for small cell lung cancer II. A longitudinal study of the EORTC core quality of life questionnaire and comparison with the Sickness Impact Profile. Acta Oncol 31:19-28, 1992
38. McHorney CA, Ware JE, Raczek AE: The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical test of validity in measuring physical and mental health constructs. Med Care 31:247-263, 1993
39. Ganz PA, Schag AC, Cheng HL: Assessing the quality of life - A study in newly-diagnosed breast cancer patients. J Clin Epidemiol 43:75-86, 1990
40. McCain NL, Zeller JM, Cella DF, et al: The influence of stress management training in HIV disease. Nursing Res 45:246-253, 1996
41. Horowitz M, Wilner N, Alvarez W: Impact of events scale: A measure of subjective stress. Psychosom Med 41:209-218, 1979
42. Yellen SB, Cella DF: Someone to live for: Social well-being, parenthood status, and decision-making in oncology. J Clin Oncol 13:1255-1264, 1995